Christopher David
Impact in
-
- Advanced Drug Delivery Systems
-
- Nanoparticle-Based Drug Delivery
Papers in
-
- HIV/AIDS drug development and treatment 2
- SARS-CoV-2 and COVID-19 Research 2
- COVID-19 Clinical Research Studies 2
- Co-authors
- Neill J. Liptrott (13 shared papers)Andrew Owen (6 shared papers)Rob J. Vandebriel (3 shared papers)Matteo Santin (1 shared paper)Sven Even Borgos (1 shared paper)Marco Siccardi (1 shared paper)Susanne Bremer‐Hoffmann (1 shared paper)Blanka Halamoda‐Kenzaoui (1 shared paper)
- Journals
- Journal of Lipid Research (3 papers)Biomedicine & Pharmacotherapy (3 papers)Pharmaceutics (2 papers)Mucosal Immunology (1 paper)Nanoscale (1 paper)
- Partner nations
- United KingdomUnited StatesNetherlands
In The Last Decade
Christopher David
16 papers receiving 176 citations
Peers
Comparison fields: 5 of 67
- Pharmaceutical Science 21
- Biomaterials 45
- Immunology 26
- Infectious Diseases 20
- Immunology and Allergy 6
Countries citing papers authored by Christopher David
This map shows the geographic impact of Christopher David's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher David with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher David more than expected).
Fields of papers citing papers by Christopher David
This network shows the impact of papers produced by Christopher David. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher David. The network helps show where Christopher David may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher David, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 60 | |
| 2 | 2016 | 29 | |
| 3 | 2004 | 19 | |
| 4 | 2021 | 16 | |
| 5 | 2020 | 12 | |
| 6 | 2021 | 11 | |
| 7 | 2022 | 6 | |
| 8 | 2021 | 4 | |
| 9 | 2023 | 4 | |
| 10 | 2022 | 4 | |
| 11 | 2023 | 3 | |
| 12 | 2023 | 3 | |
| 13 | 2022 | 3 | |
| 14 | 2004 | 3 | |
| 15 | 2004 | 3 | |
| 16 | 2023 | 1 |
About Christopher David
Christopher David is a scholar working on Immunology, Infectious Diseases, Molecular Biology, Materials Chemistry and Surgery, having authored 16 papers that have together received 181 indexed citations. Recurring topics across this work include Nanoparticles: synthesis and applications (3 papers), HIV/AIDS drug development and treatment (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Inflammasome and immune disorders (2 papers), COVID-19 Clinical Research Studies (2 papers), HIV Research and Treatment (2 papers), Diabetes Management and Research (1 paper) and Allergic Rhinitis and Sensitization (1 paper). The work is most often cited by research in Pharmaceutical Science (21 citations), Biomaterials (45 citations), Immunology (26 citations), Infectious Diseases (20 citations) and Immunology and Allergy (6 citations). Christopher David has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Neill J. Liptrott, Andrew Owen, Rob J. Vandebriel, Matteo Santin, Sven Even Borgos, Marco Siccardi, Susanne Bremer‐Hoffmann, Blanka Halamoda‐Kenzaoui, Fanny Caputo and Allen D. Cooper. Their work appears in journals such as Journal of Lipid Research, Biomedicine & Pharmacotherapy, Pharmaceutics, Mucosal Immunology and Nanoscale.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.